Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Gluten-free diet reduces risk of type 1 diabetes in mice

08.05.2014

New experiments on mice show, that mouse mothers can protect their pups from developing type 1 diabetes by eating a gluten-free diet. According to preliminary studies by reseachers at the University of Copenhagen, the findings may apply to humans.

More than 1% of the Danish population has type 1 diabetes, one of the highest incidence rates in the world.


The mouse study adds more knowledge to a field that has been object for research many years.

New experiments on mice now show a correlation between the health of the pups and their mothers eating a gluten-free diet. Our hope is that the disease may be prevented through simple dietary changes, the researchers say.

"Preliminary tests show that a gluten-free diet in humans has a positive effect on children with newly diagnosed type 1 diabetes. We therefore hope that a gluten-free diet during pregnancy and lactation may be enough to protect high-risk children from developing diabetes later in life," says assistant professor Camilla Hartmann Friis Hansen from the Department of Veterinary Disease Biology, Faculty of Health and Medical Sciences.

The findings have recently been published in the recognised journal Diabetes.

14 years of research into gluten-free diet

Findings from experiments on mice are not necessarily applicable to humans, but in this case we have grounds for optimism, says co-writer on the study professor Axel Kornerup from the Department of Veterinary Disease Biology, Faculty of Health and Medical Sciences.

"Early intervention makes a lot of sense because type 1 diabetes develops early in life. We also know from existing experiments that a gluten-free diet has a beneficial effect on type 1 diabetes," he says.

 Experiments of this type have been going on since 1999, originally initiated by Professor Karsten Buschard from the Bartholin Institute at Rigshospitalet in Copenhagen, another co-writer on the study.

"This new study beautifully substantiates our research into a gluten-free diet as an effective weapon against type 1 diabetes," Karsten Buschard explains.

Gluten-free diet affects bacteria

The experiment showed that the diet changed the intestinal bacteria in both the mother and the pups. The intestinal flora plays an important role for the development of the immune system as well as the development of type 1 diabetes, and the study suggests that the protective effect of a gluten-free diet can be ascribed to certain intestinal bacteria. The advantage of the gluten-free diet is that the only side-effect seems to be the inconvenience of having to avoid gluten, but there is no certain evidence of the effect or side-effects.

"We have not been able to start a large-scale clinical test to either prove or disprove our hypothesis about the gluten-free diet," says Karsten Buschard.

Assistant Professor Camilla Hartmann Friis Hansen is hoping that it will be possible to continue the work.

"If we find out how gluten or certain intestinal bacteria modify the immune system and the beta-cell physiology, this knowledge can be used to develop new treatments," she says.

Contact:

Professor Axel Kornerup Hansen
Cell: 30 66 34 86

Axel Kornerup Hansen | Eurek Alert!

Further reports about: Biology Cell Department Diabetes Disease Faculty Health avoid experiments

More articles from Life Sciences:

nachricht How Neural Circuits Implement Natural Vision
24.05.2016 | Albert-Ludwigs-Universität Freiburg im Breisgau

nachricht Epigenetic Modification Increases Susceptibility to Obesity and Predicts Fatty Liver Later in Life
23.05.2016 | Deutsches Institut für Ernährungsforschung Potsdam-Rehbrücke

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Atomic precision: technologies for the next-but-one generation of microchips

In the Beyond EUV project, the Fraunhofer Institutes for Laser Technology ILT in Aachen and for Applied Optics and Precision Engineering IOF in Jena are developing key technologies for the manufacture of a new generation of microchips using EUV radiation at a wavelength of 6.7 nm. The resulting structures are barely thicker than single atoms, and they make it possible to produce extremely integrated circuits for such items as wearables or mind-controlled prosthetic limbs.

In 1965 Gordon Moore formulated the law that came to be named after him, which states that the complexity of integrated circuits doubles every one to two...

Im Focus: Researchers demonstrate size quantization of Dirac fermions in graphene

Characterization of high-quality material reveals important details relevant to next generation nanoelectronic devices

Quantum mechanics is the field of physics governing the behavior of things on atomic scales, where things work very differently from our everyday world.

Im Focus: Graphene: A quantum of current

When current comes in discrete packages: Viennese scientists unravel the quantum properties of the carbon material graphene

In 2010 the Nobel Prize in physics was awarded for the discovery of the exceptional material graphene, which consists of a single layer of carbon atoms...

Im Focus: Transparent - Flexible - Printable: Key technologies for tomorrow’s displays

The trend-forward world of display technology relies on innovative materials and novel approaches to steadily advance the visual experience, for example through higher pixel densities, better contrast, larger formats or user-friendler design. Fraunhofer ISC’s newly developed materials for optics and electronics now broaden the application potential of next generation displays. Learn about lower cost-effective wet-chemical printing procedures and the new materials at the Fraunhofer ISC booth # 1021 in North Hall D during the SID International Symposium on Information Display held from 22 to 27 May 2016 at San Francisco’s Moscone Center.

Economical processing

Im Focus: Trojan horses for hospital bugs

Staphylococcus aureus usually is a formidable bacterial pathogen. Sometimes, however, weakened forms are found in the blood of patients. Researchers of the University of Würzburg have now identified one mutation responsible for that phenomenon.

Staphylococcus aureus is a bacterium that is frequently found on the human skin and in the nose where it usually behaves inconspicuously. However, once inside...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Networking 4.0: International Laser Technology Congress AKL’16 Shows New Ways of Cooperations

24.05.2016 | Event News

Challenges of rural labor markets

20.05.2016 | Event News

International expert meeting “Health Business Connect” in France

19.05.2016 | Event News

 
Latest News

Astronomers confirm faintest early-universe galaxy ever seen

24.05.2016 | Physics and Astronomy

Scientists find sustainable solutions for oysters in the future by looking into the past

24.05.2016 | Earth Sciences

Laser-manufactured customized lenses

24.05.2016 | Trade Fair News

VideoLinks
B2B-VideoLinks
More VideoLinks >>>